Literature DB >> 25707369

The Role of Environment and Lifestyle in Determining the Risk of Multiple Sclerosis.

Anna Karin Hedström1, Tomas Olsson2, Lars Alfredsson3.   

Abstract

MS is a complex disease where both genetic and environmental factors contribute to disease susceptibility. The substantially increased risk of developing MS in relatives of affected individuals gives solid evidence for a genetic base for susceptibility, whereas the modest familial risk, most strikingly demonstrated in the twin studies, is a very strong argument for an important role of lifestyle/environmental factors in determining the risk of MS, sometimes interacting with MS risk genes. Lifestyle factors and environmental exposures are harder to accurately study and quantify than genetic factors. However, it is important to identify these factors since they, as opposed to risk genes, are potentially preventable. We have reviewed the evidence for environmental factors that have been repeatedly shown to influence the risk of MS: Epstein-Barr virus (EBV) infection, ultraviolet radiation (UVR) exposure habits /vitamin D status, and smoking. We have also reviewed a number of additional environmental factors, published in the past 5 years, that have been described to influence MS risk. Independent replication, preferably by a variety of methods, may give still more firm evidence for their involvement.

Entities:  

Keywords:  Epstein–Barr virus; Gene–environment interactions; Multiple sclerosis; Obesity; Smoking; Vitamin D

Mesh:

Year:  2015        PMID: 25707369     DOI: 10.1007/7854_2015_372

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  8 in total

Review 1.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The Effect of Continuous Care on the Lifestyle of Patients with Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Masoud Khodaveisi; Fatemah Ashtarani; Ali Beikmoradi; Nahid Mohammadi; Hossein Mahjub; Mehrdokht Mazdeh; Elham Ashtarani
Journal:  Iran J Nurs Midwifery Res       Date:  2017 May-Jun

Review 3.  Environmental and genetic risk factors for MS: an integrated review.

Authors:  Emmanuelle Waubant; Robyn Lucas; Ellen Mowry; Jennifer Graves; Tomas Olsson; Lars Alfredsson; Annette Langer-Gould
Journal:  Ann Clin Transl Neurol       Date:  2019-08-07       Impact factor: 4.511

4.  Human Herpesvirus 6A Induces Dendritic Cell Death and HMGB1 Release without Virus Replication.

Authors:  Rasmus Gustafsson
Journal:  Pathogens       Date:  2021-01-11

Review 5.  Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.

Authors:  Juan Xiao; Rongbing Yang; Sangita Biswas; Xin Qin; Min Zhang; Wenbin Deng
Journal:  Int J Mol Sci       Date:  2015-04-24       Impact factor: 5.923

6.  Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.

Authors:  Till F M Andlauer; Dorothea Buck; Gisela Antony; Antonios Bayas; Lukas Bechmann; Achim Berthele; Andrew Chan; Christiane Gasperi; Ralf Gold; Christiane Graetz; Jürgen Haas; Michael Hecker; Carmen Infante-Duarte; Matthias Knop; Tania Kümpfel; Volker Limmroth; Ralf A Linker; Verena Loleit; Felix Luessi; Sven G Meuth; Mark Mühlau; Sandra Nischwitz; Friedemann Paul; Michael Pütz; Tobias Ruck; Anke Salmen; Martin Stangel; Jan-Patrick Stellmann; Klarissa H Stürner; Björn Tackenberg; Florian Then Bergh; Hayrettin Tumani; Clemens Warnke; Frank Weber; Heinz Wiendl; Brigitte Wildemann; Uwe K Zettl; Ulf Ziemann; Frauke Zipp; Janine Arloth; Peter Weber; Milena Radivojkov-Blagojevic; Markus O Scheinhardt; Theresa Dankowski; Thomas Bettecken; Peter Lichtner; Darina Czamara; Tania Carrillo-Roa; Elisabeth B Binder; Klaus Berger; Lars Bertram; Andre Franke; Christian Gieger; Stefan Herms; Georg Homuth; Marcus Ising; Karl-Heinz Jöckel; Tim Kacprowski; Stefan Kloiber; Matthias Laudes; Wolfgang Lieb; Christina M Lill; Susanne Lucae; Thomas Meitinger; Susanne Moebus; Martina Müller-Nurasyid; Markus M Nöthen; Astrid Petersmann; Rajesh Rawal; Ulf Schminke; Konstantin Strauch; Henry Völzke; Melanie Waldenberger; Jürgen Wellmann; Eleonora Porcu; Antonella Mulas; Maristella Pitzalis; Carlo Sidore; Ilenia Zara; Francesco Cucca; Magdalena Zoledziewska; Andreas Ziegler; Bernhard Hemmer; Bertram Müller-Myhsok
Journal:  Sci Adv       Date:  2016-06-17       Impact factor: 14.136

7.  Multiple Sclerosis as a Syndrome-Implications for Future Management.

Authors:  Christopher M Dwyer; Linda Thien-Trang Nguyen; Luke M Healy; Ranjan Dutta; Samuel Ludwin; Jack Antel; Michele D Binder; Trevor J Kilpatrick
Journal:  Front Neurol       Date:  2020-08-28       Impact factor: 4.003

8.  Factors affecting the risk of relapsing-onset and progressive-onset multiple sclerosis.

Authors:  Tomas Olsson; Lars Alfredsson; Anna Karin Hedström; Jan Hillert
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-05-13       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.